Safety results of a phase III randomized trial of adjuvant treatment with 5-fluorouracil and folinic acid with or without irinotecan, in Dukes B2 and C colon cancer

被引:0
|
作者
Papakostas, P. [1 ]
Kalofonos, H. P. [1 ]
Pentheroudakis, G. [1 ]
Timotheadou, E. [1 ]
Papadimitriou, C. [1 ]
Tsavdaridis, D. [1 ]
Economopoulos, T. [1 ]
Galani, E. [1 ]
Bafaloukos, D. [1 ]
Aravantinos, G. [1 ]
机构
[1] Hellen Cooperat Oncol Grp, Athens, Greece
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4053
引用
收藏
页数:1
相关论文
共 50 条
  • [1] A randomised phase III intergroup trial comparing high-dose infusional 5-fluorouracil with or without folinic acid with standard bolus 5-fluorouracil/folinic acid in the adjuvant treatment of stage III colon cancer: The Pan-European Trial in Adjuvant Colon Cancer 2 study
    Koehne, Claus-Henning
    Bedenne, Laurent
    Carrato, Alfredo
    Bouche, Olivier
    Popov, Ivan
    Gaspa, Losa
    Valladares, Manuel
    Rougier, Phillipe
    Gog, Christiane
    Reichardt, Peter
    Wils, Jacques
    Pignatti, Francesco
    Biertz, Frank
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (08) : 1868 - 1875
  • [2] Adjuvant chemotherapy for Dukes B2 and C colon cancer combining 5-fluorouracil and folinic acid with or without carboplatin. Feasibility and comparison between standard and chronomodulated deliveries
    Focan, C
    Bury, J
    Matus, G
    Graas, MP
    Kreutz, F
    Longree, L
    Moeneclaey, N
    David, A
    Focan-Henrard, D
    PATHOLOGIE BIOLOGIE, 2005, 53 (05): : 281 - 284
  • [3] Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer
    Erlichman, C
    O'Connell, M
    Kahn, M
    Marsoni, S
    Torri, V
    Tardio, B
    Zaniboni, A
    Pancera, G
    Martignoni, G
    Labianca, R
    Barni, A
    Seitz, JF
    Milan, C
    Bedenne, L
    Giovannini, M
    Letreut, YP
    Skillings, J
    Shepard, L
    Zee, B
    Petrioli, R
    Francini, G
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) : 1356 - 1363
  • [4] Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer
    Porschen, R
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1996, 34 (09): : 549 - 551
  • [5] An alternating regimen of irinotecan/5-fluorouracil/folinic acid and oxaliplatin/5-fluorouracil/folinic acid in metastatic colorectal cancer: A phase II trial
    Ferrari, V
    Valcamonico, F
    Amoroso, V
    Simoncini, E
    Vassalli, L
    Marpicati, P
    Rangoni, G
    Grisanti, S
    Pasinetti, N
    Marini, G
    ONCOLOGY, 2005, 69 (04) : 283 - 289
  • [6] Adjuvant Chemotherapy of Locally Advanced Colon Cancer: Final Results of a Randomized Trial Comparing 5-Fluorouracil and Folinic Acid with Folfiri
    Paschke, Stephan
    Hebart, Holger
    Goeb, Roland
    Staib, Ludger
    Fleck, Ullrich
    Henne-Bruns, Doris
    Sander, Silvia
    Link, Karl-Heinrich
    Kornmann, Marko
    VISCERAL MEDICINE, 2019, 35 (02) : 124 - 132
  • [7] FOLINIC ACID AND 5-FLUOROURACIL AS ADJUVANT CHEMOTHERAPY IN COLON-CANCER
    FRANCINI, G
    PETRIOLI, R
    LORENZINI, L
    MANCINI, S
    ARMENIO, S
    TANZINI, G
    MARSILI, S
    AQUINOA
    MARZOCCA, G
    CIVITELLI, S
    MARIANI, L
    DESANDO, D
    BOVENGA, S
    LORENZI, M
    GASTROENTEROLOGY, 1994, 106 (04) : 899 - 906
  • [8] FOLINIC ACID DOES IMPROVE 5-FLUOROURACIL ACTIVITY INVIVO - RESULTS OF A PHASE-III STUDY COMPARING 5-FLUOROURACIL TO 5-FLUOROURACIL AND FOLINIC ACID IN ADVANCED COLON CANCER-PATIENTS
    BOBBIOPALLAVICINI, E
    PORTA, C
    MORONI, M
    SPAGHI, A
    CASAGRANDA, I
    NASTASI, G
    JOURNAL OF CHEMOTHERAPY, 1993, 5 (01) : 52 - 55
  • [9] 5-FLUOROURACIL AND FOLINIC ACID WITH OR WITHOUT ALPHA-2C INTERFERON IN THE TREATMENT OF METASTATIC COLORECTAL-CANCER - PRELIMINARY-RESULTS OF A MULTICENTER PROSPECTIVE RANDOMIZED PHASE-III TRIAL
    MOSER, R
    HAUSMANINGER, H
    LUDWIG, H
    FRIDRIK, M
    SCHMIDT, H
    MLINERITSCH, B
    PECHERSTORFER, M
    MICHLMAYR, G
    KOPF, C
    SAMONIGG, H
    ONKOLOGIE, 1995, 18 (02): : 131 - 135
  • [10] 5-FLUOROURACIL MONOTHERAPY VERSUS FOLINIC ACID AND 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER - RESULTS OF A RANDOMIZED TRIAL
    STEINKE, B
    GUNTHER, E
    HIRSCHMANN, W
    SONDERN, W
    KONICZECK, KH
    WANDER, HE
    NATT, F
    WAGNER, T
    HINRICHS, HF
    ROTH, W
    ONKOLOGIE, 1993, 16 (04): : 252 - 259